Level Bio Balance Sheet Health
Financial Health criteria checks 4/6
Level Bio has a total shareholder equity of SEK4.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK14.2M and SEK9.4M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 1.96m |
| Equity | SEK 4.80m |
| Total liabilities | SEK 9.41m |
| Total assets | SEK 14.20m |
Recent financial health updates
No updates
Recent updates
Do AlphaHelix Molecular Diagnostics's (NGM:ALPH) Earnings Warrant Your Attention?
Jun 02
Should You Be Adding AlphaHelix Molecular Diagnostics (NGM:ALPH) To Your Watchlist Today?
Feb 10I Ran A Stock Scan For Earnings Growth And AlphaHelix Molecular Diagnostics (NGM:ALPH) Passed With Ease
Nov 03AlphaHelix Molecular Diagnostics AB (publ) (NGM:ALPH) Stock Rockets 35% As Investors Are Less Pessimistic Than Expected
Aug 18Do Its Financials Have Any Role To Play In Driving AlphaHelix Molecular Diagnostics AB (publ)'s (NGM:ALPH) Stock Up Recently?
Mar 07Declining Stock and Decent Financials: Is The Market Wrong About AlphaHelix Molecular Diagnostics AB (publ) (NGM:ALPH)?
Nov 22Financial Position Analysis
Short Term Liabilities: LEVBIO's short term assets (SEK9.5M) exceed its short term liabilities (SEK8.9M).
Long Term Liabilities: LEVBIO's short term assets (SEK9.5M) exceed its long term liabilities (SEK517.0K).
Debt to Equity History and Analysis
Debt Level: LEVBIO is debt free.
Reducing Debt: LEVBIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LEVBIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: LEVBIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 48.1% each year